We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
VYNE Therapeutics Inc | NASDAQ:VYNE | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.12 | 4.80% | 2.62 | 2.50 | 8.30 | 2.7682 | 2.53 | 2.54 | 34,681 | 05:00:09 |
CUSIP No. 92941V100
|
|
(1) Names of reporting persons Point72 Asset Management, L.P.
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization Delaware
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 0 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 0 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
0 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 0% (see Item 4)
|
|
(12) Type of reporting person (see instructions) PN
|
CUSIP No. 92941V100
|
|
(1) Names of reporting persons Point72 Capital Advisors, Inc.
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization Delaware
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 0 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 0 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
0 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 0% (see Item 4)
|
|
(12) Type of reporting person (see instructions) CO
|
CUSIP No. 92941V100
|
|
(1) Names of reporting persons Cubist Systematic Strategies, LLC
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization Delaware
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 25,500 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 25,500 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
25,500 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) <0.1% (see Item 4)
|
|
(12) Type of reporting person (see instructions) OO
|
CUSIP No. 92941V100
|
|
(1) Names of reporting persons Point72 Hong Kong Limited
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization Hong Kong
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 540 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 540 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
540 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) <0.1% (see Item 4)
|
|
(12) Type of reporting person (see instructions) OO
|
CUSIP No. 92941V100
|
|
(1) Names of reporting persons Steven A. Cohen
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization United States
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 26,040 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 26,040 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
26,040 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) <0.1% (see Item 4)
|
|
(12) Type of reporting person (see instructions) IN
|
1 Year VYNE Therapeutics Chart |
1 Month VYNE Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions